Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Anthropic delays planned IPO from October to November - WSJ
• Lumentum shares rise on analyst upgrades, AI demand outlook